NCT06451822View on ClinicalTrials.gov

Efficacy and Performance Evaluation of mIntense L+AS 25 mg/ml Hyaluronic Acid for the Correction of Moderate to Deep Wrinkles and Folds

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 3, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Skin AgingSkin Wrinkling
Interventions
DEVICE

mIntense L+AS

The investigated dermal filler mIntense L+AS is intended to be used as a temporary filler, administered by intradermal or subcutaneous injections, to correct small skin defects, such as wrinkles or scars.

Trial Locations (1)

1000

"Medical Center Ramus EOOD", Sofia

All Listed Sponsors
lead

Mesoestetic Pharma Group S.L.

INDUSTRY